Report on China’s Oral Contraceptive Drugs Industry
Oral contraceptive drug has two major components: progesterone and estrogen, which achieve contraception by taking effects on physiology. Through detailed data analysis, this article is to show China’s utilization rate of oral contraceptive drug is considerably lower than that in developed country, and is of low total utilization rate, but with a huge number of users absolutely. As a part of the .national policy of family planning, China practices the national supply system of basic oral contraceptive drug, at the same time, the market of oral contraceptive drug as a commodity is also very competitive, thus this article is to elaborate on these aspects, and finally it describes the R&D direction of oral contraceptive drug.
1 SUMMARY OF ORAL CONTRACEPTIVE DRUG
1.1 Summary of contraceptive method
1.2 Principles and characteristics of oral contraceptive drug
1.3 History evolution of oral contraceptive drug
1.4 Classification of oral contraceptive drug
2. MARKET DYNAMICS OF ORAL CONTRACEPTIVE DRUG
2.1 Usage of oral contraceptive drug globally
2.2 Usage of oral contraceptive drug in China
2.2.1 Analysis of usage status of China’s oral contraceptive drug
2.2.2 Reasons of usage status of China’s oral contraceptive drug
2.3 Supply situation of China’s oral contraceptive drug
2.3.1 Supply situation of the government
2.3.2 Supply situation of the market
3. R&D TREND OF ORAL CONTRACEPTIVE DRUG
1.1 Summary of contraceptive method
1.2 Principles and characteristics of oral contraceptive drug
1.3 History evolution of oral contraceptive drug
1.4 Classification of oral contraceptive drug
2. MARKET DYNAMICS OF ORAL CONTRACEPTIVE DRUG
2.1 Usage of oral contraceptive drug globally
2.2 Usage of oral contraceptive drug in China
2.2.1 Analysis of usage status of China’s oral contraceptive drug
2.2.2 Reasons of usage status of China’s oral contraceptive drug
2.3 Supply situation of China’s oral contraceptive drug
2.3.1 Supply situation of the government
2.3.2 Supply situation of the market
3. R&D TREND OF ORAL CONTRACEPTIVE DRUG